Biopharmaceutical

Bringing a new drug to market is an expensive and risky proposition from basic genomic and proteomic research through target identification and lead optimization to clinical trials and manufacturing. Sionex is investigating opportunities associated with the entire biopharmaceutical value chain including basic disease research.

We believe microDMx™ sensor chip technology can be applied to the complex understanding of basic disease research by enabling a faster, easier and more cost effective solution to some of the information derived from the human genome project.

In the manufacturing process contamination and/or cross-contamination is a constant battle; microDMx™ sensor chip technologies are capable of providing simple handheld devices to help ensure the integrity of a manufacturing process and help maintain high standards for QA/QC.

Protection by Detection™

...microDMx™ technology can help protect the world's population by empowering pharmaceutical development & manufacturing

To obtain a copy of Sionex's whitepapers please register here.